12/20/2017 (supposedly?) FINAL RULE establishing that certain active ingredients used in nonprescription (also known as over-the-counter or OTC) antiseptic products intended for use by health care professionals in a hospital setting or other health...

2016, 21337 page 15 & 16

Assoc for Professions in Infection Control & Epidemiology. Resources to Assist with COVID-19 Response Need additional IP assistance in your facility? APIC Consulting Services has board-certified consultants ready to assist long-term care facilities with remote surveillance, COVID-19-specific policies for protecting resident & employee health, and COVID-19 prevention staff training. Visit our website for more information.

In this inaugural report, cannabis cultivators across the United States and Canada weigh in on their humidity-regulation methodologies, and experts share what cultivators must understand about the science of humidity to keep plants healthy and thriving.

Catheter recommendations that could use CD

Residential water treatment devices can't refer to chlorination reduction unless certified or only described as "aesthetic"?

Product listed Amosilq (benzalkonium chloride/silica complex) ingredient rather than just BAK, plus made extravagant claims, etc

All health departments must be able to identify new cases, break chains of transmission, and protect first responders and health care workers from infection.

Information about handwashing and hand hygiene

Find out if a utility, design, or plan patent is right for you

The many ways FDA is responsible for protecting the public health.

Under U.S. patent law, any person who "invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent." In general, this means you must satisfy the following four requirements to qualify for a patent:

Trade-off benefits of options for various approaches. Japan promoted incremental innovation (which introduces product patents & maintains reasonable drug prices, without discouraging innovation by domestic firms--coordinated policy instruments, i.e. narrow patent scope, adequate patentability, and cross-licensing). India’s new patent policy demonstrates that developing countries may want to shorten the exclusivity period on new drugs by, inter alia, raising the hurdle on patentability (which will strengthen the competitiveness of domestic firms in global generics markets, but may reduce incentives to invest in incremental innovation in domestic markets).

Vocabulary used in EPA Integrated Risk Information System (IRIS)

EPA label review manual -Chapter 7. July 2014

2004 draft. GHS criteria summary

Concentration levels for effective hand sanitizers

Centers for Medicare & Medicaid Services (CMS)